Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis -: Relation to inflammatory activity

被引:52
作者
van Walderveen, MAA
Truyen, L
van Oosten, BW
Castelijns, JA
Nijcholt, GJLA
van Waesberghe, JHTM
Polman, C
Barkhof, F
机构
[1] Vrije Univ Amsterdam, Acad Hosp, Magnet Resonance Ctr Multiple Sclerosis Res, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Acad Hosp, Dept Radiol, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Acad Hosp, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1001/archneur.56.3.345
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate whether degree of inflammatory activity in multiple sclerosis, expressed by frequency of gadolinium enhancement, has prognostic value for development of hypointense lesions on T-1-weighted spin-echo magnetic resonance images, a putative marker of tissue destruction. Design: Cohort design with long-term follow-up. Thirty-eight eight patients with multiple sclerosis who in the past had been monitored with monthly gadolinium-enhanced magnetic resonance imaging for a median period of 10 months (range, 6-12 months) were reexamined after a median period of 40.5 months (range, 33-80 months). Setting: Magnetic Resonance Center for Multiple Sclerosis Research, Amsterdam, the Netherlands, referral center. Main Outcome Measures: The low enhancing lesion rate (median number of gadolinium-enhancing lesions per monthly scan) during initial monthly follow-up; hypointense T-1 and hyperintense T-2 lesion load at first and last visit. Results: The number of enhancing lesions on entry scan correlated with the new enhancing lesions rate (r = 0.64; P<.001, Spearman rank correlation coefficient). The new enhancing lesion rate correlated with yearly increase in T-1 lesions rate; P<.001, Spearman rank correlation coefficient) and T-2 (r = 0.47; P<.01, Spearman rank correlation coefficient) lesion load, initial T-1 lesion load correlated more strongly with yearly increase in T-1 lesion load (r = 0.68; P<.01, Spearman rank correlation coefficient). Conclusions: Degree of inflammatory activity only partially predicted increase in T-1 (and T-2) lesion load at long-term follow-up. Initial T-1 lesion load strongly contributed to subsequent increase in hypointense T-1 lesion load, suggesting that there is a subpopulation of patients with multiple sclerosis who are prone to develop destructive lesions.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 32 条
[1]   MAGNETIC-RESONANCE RELAXATION-TIME MAPPING IN MULTIPLE-SCLEROSIS - NORMAL APPEARING WHITE-MATTER AND THE INVISIBLE LESION LOAD [J].
BARBOSA, S ;
BLUMHARDT, LD ;
ROBERTS, N ;
LOCK, T ;
EDWARDS, RHT .
MAGNETIC RESONANCE IMAGING, 1994, 12 (01) :33-42
[2]   LIMITED DURATION OF THE EFFECT OF METHYLPREDNISOLONE ON CHANGES ON MRI IN MULTIPLE-SCLEROSIS [J].
BARKHOF, F ;
TAS, MW ;
FREQUIN, STFM ;
SCHELTENS, P ;
HOMMES, OR ;
NAUTA, JJP ;
VALK, J .
NEURORADIOLOGY, 1994, 36 (05) :382-387
[3]   RELAPSING-REMITTING MULTIPLE-SCLEROSIS - SEQUENTIAL ENHANCED MR IMAGING VS CLINICAL FINDINGS IN DETERMINING DISEASE-ACTIVITY [J].
BARKHOF, F ;
SCHELTENS, P ;
FREQUIN, STFM ;
NAUTA, JJP ;
TAS, MW ;
VALK, J ;
HOMMES, OR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1992, 159 (05) :1041-1047
[4]   Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology [J].
Bruck, W ;
Bitsch, A ;
Kolenda, H ;
Bruck, Y ;
Stiefel, M ;
Lassmann, H .
ANNALS OF NEUROLOGY, 1997, 42 (05) :783-793
[5]   INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DUQUETTE, P ;
GIRARD, M ;
DESPAULT, L ;
DUBOIS, R ;
KNOBLER, RL ;
LUBLIN, FD ;
KELLEY, L ;
FRANCIS, GS ;
LAPIERRE, Y ;
ANTEL, J ;
FREEDMAN, M ;
HUM, S ;
GREENSTEIN, JI ;
MISHRA, B ;
MULDOON, J ;
WHITAKER, JN ;
EVANS, BK ;
LAYTON, B ;
SIBLEY, WA ;
LAGUNA, J ;
KRIKAWA, J ;
PATY, DW ;
OGER, JJ ;
KASTRUKOFF, LF ;
MOORE, GRW ;
HASHIMOTO, SA ;
MORRISON, W ;
NELSON, J ;
GOODIN, DS ;
MASSA, SM ;
GUTTERIDGE, E ;
ARNASON, BGW ;
NORONHA, A ;
REDER, AT ;
MARTIA, R ;
EBERS, GC ;
RICE, GPA ;
LESAUX, J ;
JOHNSON, KP ;
PANITCH, HS ;
BEVER, CT ;
CONWAY, K ;
WALLENBERG, JC ;
BEDELL, L ;
VANDENNOORT, S ;
WEINSHENKER, B ;
WEISS, W ;
REINGOLD, S ;
PACHNER, A ;
TAYLOR, W .
NEUROLOGY, 1993, 43 (04) :655-661
[6]   SERIAL CONTRAST-ENHANCED MAGNETIC-RESONANCE-IMAGING IN PATIENTS WITH EARLY RELAPSING-REMITTING MULTIPLE-SCLEROSIS - IMPLICATIONS FOR TREATMENT TRIALS [J].
FRANK, JA ;
STONE, LA ;
SMITH, ME ;
ALBERT, PS ;
MALONI, H ;
MCFARLAND, HF .
ANNALS OF NEUROLOGY, 1994, 36 :S86-S90
[7]   DURATION AND SELECTIVITY OF BLOOD-BRAIN-BARRIER BREAKDOWN IN CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS STUDIED BY GADOLINIUM-DTPA AND PROTEIN MARKERS [J].
HAWKINS, CP ;
MUNRO, PMG ;
MACKENZIE, F ;
KESSELRING, J ;
TOFTS, PS ;
DUBOULAY, EPGH ;
LANDON, DN ;
MCDONALD, WI .
BRAIN, 1990, 113 :365-378
[8]   CORRELATION OF SPECTROSCOPY AND MAGNETIZATION-TRANSFER IMAGING IN THE EVALUATION OF DEMYELINATING LESIONS AND NORMAL APPEARING WHITE-MATTER IN MULTIPLE-SCLEROSIS [J].
HIEHLE, JF ;
LENKINSKI, RE ;
GROSSMAN, RI ;
DOUSSET, V ;
RAMER, KN ;
SCHNALL, MD ;
COHEN, JA ;
GONZALEZSCARANO, F .
MAGNETIC RESONANCE IN MEDICINE, 1994, 32 (03) :285-293
[9]   Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis [J].
Jacobs, LD ;
Cookfair, DL ;
Rudick, RA ;
Herndon, RM ;
Richert, JR ;
Salazar, AM ;
Fischer, JS ;
Goodkin, DE ;
Granger, CV ;
Simon, JH ;
Alam, JJ ;
Bartoszak, DM ;
Bourdette, DN ;
Braiman, J ;
Brownscheidle, CM ;
Coats, ME ;
Cohan, SL ;
Dougherty, DS ;
Kinkel, RP ;
Mass, MK ;
Munschauer, FE ;
Priore, RL ;
Pullicino, PM ;
Scherokman, BJ ;
WeinstockGuttman, B ;
Whitman, RH ;
Baird, WC ;
Fillmore, M ;
Bona, LM ;
ColonRuiz, ME ;
Nadine, BS ;
Donovan, A ;
Bennett, S ;
Kieffer, YM ;
Umhauer, MA ;
Miller, CE ;
Kilic, AK ;
Sargent, EL ;
Schachter, M ;
Shucard, DW ;
Weider, V ;
Catalano, BA ;
Cervi, JM ;
Czekay, C ;
Farrell, JL ;
Filippini, JS ;
Matyas, RC ;
Michienzi, KE ;
Ito, M ;
OMalley, JA .
ANNALS OF NEUROLOGY, 1996, 39 (03) :285-294
[10]   COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
JOHNSON, KP ;
BROOKS, BR ;
COHEN, JA ;
FORD, CC ;
GOLDSTEIN, J ;
LISAK, RP ;
MYERS, LW ;
PANITCH, HS ;
ROSE, JW ;
SCHIFFER, RB ;
VOLLMER, T ;
WEINER, LP ;
WOLINSKY, JS ;
BIRD, SJ ;
CONSTANTINESCU, C ;
KOLSON, DL ;
GONZALEZSCARANO, F ;
BRENNAN, D ;
PFOHL, D ;
MANDLER, RN ;
ROSENBERG, GA ;
JEFFREY, C ;
BARGER, GR ;
GANDHI, B ;
MOORE, PM ;
ROGERS, LR ;
LISAK, D ;
SMITH, L ;
ELLISON, GW ;
BAUMHEFNER, RW ;
CRAIG, SL ;
JALBUT, SS ;
KATZ, E ;
CONWAY, KL ;
BURNS, JB ;
SHIBA, C ;
GIANG, DW ;
PETRIE, MD ;
GUARNACCIA, JB ;
ANDERSON, S ;
MCKEON, A ;
MCCARTHY, M ;
THOMAS, AB ;
VRIESENDORP, FJ ;
AUSTIN, SG ;
LINDSEY, JW ;
DIMACHKIE, M ;
CERRETA, E ;
KACHUCK, N ;
MCCARTHY, KA .
NEUROLOGY, 1995, 45 (07) :1268-1276